Home › Executives › David Endicott
David Endicott

David Endicott

Chief Executive Officer at Alcon

Alcon•Fort Worth, Texas, United States

View LinkedIn Profile
Experience40+ Years
LevelLeadership

Executive Overview

David is the Chief Executive Officer of Alcon, the largest eye care device company in the world with complementary businesses is surgical and vision care. In 2018, David was named CEO of Alcon, a division of Novartis, and in 2019 he completed its separation, spin out and public listing. Today, under David’s leadership more than 25,000 associates work in locations around the globe to help people in over 120 countries see brilliantly.

Career Timeline

Professional employment history
  • AlconCurrent
    Jul 2016–Present· 10 yrs 2 mos
    • Chief Executive OfficerCurrent
      Jul 2018–Present
    • Chief Operating Officer, IT
      Jul 2016–Jun 2018
  • Pfizer
    Mar 2014–Jun 2016· 2 yrs 3 mos
    • President, Hospira Infusion Systems - A Pfizer Company
      Mar 2014–Jun 2016
  • Allergan
    1986–2013· 27 yrs
    • President Allergan Medical and President Asia and Latin America
      2010–2013
    • President, Europe, Africa & Middle East
      2005–2010
    • Senior Vice President & Business Head, U.S. Specialty Pharmaceuticals
      2004–2005
    • Other commercial roles
      1986–2004

Education

Advanced Management Program

Harvard Business School

Bachelor of Arts (BA)

Chemistry

Whitman College

Master of Business Administration - MBA

University of Southern California

Executive Relationship Map

Reports To
David Endicott
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer

Executive Network Preview

BizKonnect has mapped this leadership network including reporting hierarchies, peer connections, and cross-functional relationships.

Verified Contact Information
Email & Direct Dial
Org Chart & Reporting Lines
Buying Committee Insights
AI-Powered Account Mapping

Skills & Expertise

20 of 20 skills
OTC drugsSpecialty DrugsRegulatory AffairsCustomer Relationship ManagementRegulatory SubmissionsM&AProduct LaunchTeam BuildingEmerging MarketsProfit MaximizationAcquisition IntegrationStrategic PlanningPharmacovigilanceConsumer BrandingOrganizational DevelopmentGrowth StrategiesGlobal ManagementPharmaceutical IndustryInternational InvestmentR&D Portfolio Planning